Literature DB >> 26177302

Seroepidemiology of diphtheria and pertussis in Beijing, China: A cross-sectional study.

Xiaomei Li1, Meng Chen1, Tiegang Zhang1, Juan Li1, Yang Zeng1, Li Lu1.   

Abstract

The aim of this study was to assess the level of humoral immunity against diphtheria and pertussis by measuring IgG to diphtheria toxoid (DT) and pertussis toxin (PT) in general population of Beijing. A total of 2147 subjects aged 0-74 y were selected with a random sample of resident population in Beijing. The information of socio-demographic characteristics, vaccination history, disease history of diphtheria and pertussis were collected for each subject by questionnaire. Serum samples were tested for IgG antibodies to DT and PT by using commercial ELISA kits. The overall positivity rate of anti-DT IgG was 66.28% with the mean concentration of 2.169 IU/ml. Age stratified data showed that the highest positivity rate of 97.63% was observed in 1-4 y and the rates decreased with age. The positivity rates were only around 50% or below since 25 y old. The positivity rate of anti-PT IgG was 12.34% with the mean concentration of 15.163 IU/ml. The highest level of positivity rate (22.23%) and antibody level (23.101 IU/ml) was seen in <1 year old. In subjects older than 10 y old, the anti-PT IgG positivity rate was 10.19%-13.51% and concentration was 13.295 IU/ml -16.353 IU/ml, with no significant differences between these groups (χ2 = 1.664, P = 0.948; F = 0.369, P = 0.899). The subjects with anti-PT IgG ≥ 100 IU/ml were observed in nearly all the groups older than 5 y except for 10-14 age group. The estimated incidences of pertussis infection were higher than 6000/100000 in these age groups. A sharp increase of immunity level of diphtheria was observed at 1 y and 6 y respectively, which was consistent with the current immunization schedule. But there was no significant increase of immunity to pertussis observed after booster immunization at 18-24 months, but the proportions of undetectable were lowest in <1, 1, 2 years in children <14 years. As shown in the present study, the adult population was generally lack of protective antibody against diphtheria and all the age groups showed a low immunity to pertussis indicating the potential risk of transmission and outbreaks of the 2 diseases in Beijing.

Entities:  

Keywords:  diphtheria; pertussis; seroepidemiology

Mesh:

Substances:

Year:  2015        PMID: 26177302      PMCID: PMC4635875          DOI: 10.1080/21645515.2015.1062954

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  16 in total

1.  Immunity against diphtheria among children and adults in Izmir, Turkey.

Authors:  Zafer Kurugöl; Levent Midyat; Ebru Türkoğlu; Ayşegül Işler
Journal:  Vaccine       Date:  2011-04-19       Impact factor: 3.641

2.  [Analysis of diphtheria antibody levels in healthy population in Beijing municipal, 2007].

Authors:  Xiao-mei Li; Dong-lei Liu; Jie Yang
Journal:  Zhongguo Yi Miao He Mian Yi       Date:  2010-06

3.  2010 pertussis outbreak and updated Tdap recommendations.

Authors:  Gillian C Bell; Stephan L Foster
Journal:  J Am Pharm Assoc (2003)       Date:  2011 Jan-Feb

4.  Seroprevalence of antibodies to pertussis and diphtheria among healthy adults in China.

Authors:  Qi Zhang; Fulian Han; Qing Nie; Hongyu Ren; Baoqiang Zhang; Qiyong Liu; Qiushui He; Zhujun Shao
Journal:  J Infect       Date:  2011-08-16       Impact factor: 6.072

5.  The seroepidemiology of immunoglobulin G antibodies against pertussis toxin in China: a cross sectional study.

Authors:  Qi Zhang; Huizhen Zheng; Meizhen Liu; Ke Han; Jun Shu; Chenggang Wu; Ning Xu; Qiushui He; Huiming Luo
Journal:  BMC Infect Dis       Date:  2012-06-20       Impact factor: 3.090

6.  Reduced risk of pertussis among persons ever vaccinated with whole cell pertussis vaccine compared to recipients of acellular pertussis vaccines in a large US cohort.

Authors:  Maxwell A Witt; Larry Arias; Paul H Katz; Elizabeth T Truong; David J Witt
Journal:  Clin Infect Dis       Date:  2013-03-13       Impact factor: 9.079

Review 7.  Sources of pertussis infection in young infants: a review of key evidence informing targeting of the cocoon strategy.

Authors:  K E Wiley; Y Zuo; K K Macartney; P B McIntyre
Journal:  Vaccine       Date:  2012-11-29       Impact factor: 3.641

8.  Antibodies to tetanus, diphtheria and pertussis among healthy adults vaccinated according to the French vaccination recommendations.

Authors:  Odile Launay; Christine Toneatti; Claire Bernède; Elisabeth Njamkepo; Karine Petitprez; Annie Leblond; Sylvie Larnaudie; Catherine Goujon; Marie-Noelle Ungeheuer; Faïza Ajana; Christian Raccurt; Jean Beytout; Christian Chidiac; Damien Bouhour; Didier Guillemot; Nicole Guiso
Journal:  Hum Vaccin       Date:  2009-05-09

9.  Comparative effectiveness of acellular versus whole-cell pertussis vaccines in teenagers.

Authors:  Nicola P Klein; Joan Bartlett; Bruce Fireman; Ali Rowhani-Rahbar; Roger Baxter
Journal:  Pediatrics       Date:  2013-05-20       Impact factor: 7.124

10.  Increased population prevalence of low pertussis toxin antibody levels in young children preceding a record pertussis epidemic in Australia.

Authors:  Patricia Campbell; Peter McIntyre; Helen Quinn; Linda Hueston; Gwendolyn L Gilbert; Jodie McVernon
Journal:  PLoS One       Date:  2012-04-27       Impact factor: 3.240

View more
  11 in total

Review 1.  Immune persistence after pertussis vaccination.

Authors:  Zhiyun Chen; Qiushui He
Journal:  Hum Vaccin Immunother       Date:  2017-01-03       Impact factor: 3.452

2.  Decline of serologic immunity to diphtheria, tetanus and pertussis with age suggested a full life vaccination in mainland China.

Authors:  Dandan Liu; Xiaoping Cheng; Shi Wei; Lin Yuan; Changhui Chen; Kaihu Yao
Journal:  Hum Vaccin Immunother       Date:  2021-01-30       Impact factor: 3.452

3.  A high seroprevalence of antibodies to pertussis toxin among Japanese adults: Qualitative and quantitative analyses.

Authors:  Takumi Moriuchi; Nao Otsuka; Yukihiro Hiramatsu; Keigo Shibayama; Kazunari Kamachi
Journal:  PLoS One       Date:  2017-07-10       Impact factor: 3.240

Review 4.  Tetanus-diphtheria-acellular pertussis vaccination for adults: an update.

Authors:  Hyo-Jin Lee; Jung-Hyun Choi
Journal:  Clin Exp Vaccine Res       Date:  2017-01-25

5.  Seroprevalence of diphtheria and pertussis immunoglobulin G among children with pneumonia in Ji'nan, China.

Authors:  Qinghong Meng; Lijun Li; Wei Shi; Qing Wang; Mingjie Ding; Yanqin Liu; Xiang Ma; Kaihu Yao
Journal:  BMC Pediatr       Date:  2018-12-05       Impact factor: 2.125

6.  Seroprevalence of Maternal and Cord Antibodies Specific for Diphtheria, Tetanus, Pertussis, Measles, Mumps and Rubella in Shunyi, Beijing.

Authors:  Qing-Hong Meng; Ying Liu; Jin-Qian Yu; Li-Jun Li; Wei Shi; Ying-Jie Shen; Li Li; Shi-Na Zhan; Fan Yang; Ya-Juan Wang; Kai-Hu Yao
Journal:  Sci Rep       Date:  2018-08-29       Impact factor: 4.379

7.  Seroprevalence of IgG antibodies against diphtheria antitoxin among migrant workers in Singapore, 2016-2019.

Authors:  Vernon Jian Ming Lee; Yee Sin Leo; Li Wei Ang; Qi Gao; Lin Cui; Aysha Farwin; Matthias Paul Han Sim Toh; Irving Charles Boudville; Mark I-Cheng Chen; Angela Chow; Raymond Tzer-Pin Lin
Journal:  BMC Public Health       Date:  2022-01-16       Impact factor: 3.295

Review 8.  Whole Genome Sequencing for Surveillance of Diphtheria in Low Incidence Settings.

Authors:  Helena M B Seth-Smith; Adrian Egli
Journal:  Front Public Health       Date:  2019-08-21

Review 9.  Bordetella pertussis in School-Age Children, Adolescents, and Adults: A Systematic Review of Epidemiology, Burden, and Mortality in Asia.

Authors:  Denis Macina; Keith E Evans
Journal:  Infect Dis Ther       Date:  2021-04-29

10.  Seroprevalence Study of Pertussis in Adults at Childbearing Age and Young Infants Reveals the Necessity of Booster Immunizations in Adults in China.

Authors:  Zhiyun Chen; Jie Pang; Nan Zhang; Ning Chen; Yiwei Ding; Qiushui He
Journal:  Vaccines (Basel)       Date:  2022-01-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.